Daily Dose: Buy low for the second half

0 Comments

While the baseball world pauses for the All-Star break, here are a
dozen players who fantasy owners should be looking to acquire with
their value low …

Scott Baker – Baker got off to a homerific start as he battled
shoulder soreness and inconsistent mechanics, going 0-4 with a 9.15 ERA
and eight long balls after four outings. He’s been his usual self since
then, going 7-3 with a 4.46 ERA and 66/16 K/BB ratio in 81 innings. As
an extreme fly-ball pitcher homers will always hurt Baker, but he
hasn’t served up more than two in a start since April 22.

Cole Hamels – On the surface it looks like Hamels has declined
significantly this season, going 5-5 with a 4.87 ERA after last year’s
3.07 mark. However, the bulk of his struggles stem from an
unsustainably terrible .348 batting average on balls in play that’s 53
points worse than his career rate. Once that number gets back to normal
his strikeout and walk rates are as strong as usual and he’ll be fine.

Howie Kendrick – Kendrick has plenty of flaws in his game, but
there’s no doubt that he can post big batting averages and when the
Angels demoted him to the minors last month it just made him
undervalued. He came back two weeks ago, has hit above .300 since
returning, and the 25-year-old career .294 hitter should post his usual
high-average, low-power, solid-speed numbers down the stretch.

Cliff Lee – He hasn’t pitched as well as he did while winning the Cy
Young award last season, but the difference isn’t nearly as huge as his
lowly 4-9 record would indicate. Lee has suffered from a severe lack of
bullpen and run support, but his luck can’t help but improve and his
record could reverse itself in the second half if he keeps pitching
like the guy with a 3.43 ERA and 93/33 K/BB ratio.

Ricky Nolasco – Much like Baker, Nolasco’s brutal start to the
season masks an otherwise solid performance. His secondary numbers were
strong even when the Marlins demoted him to the minors, and since
returning he’s gone 4-2 with a 2.68 ERA and 53/8 K/BB ratio in 47
innings spread over seven starts. Since the start of last year he has
the eighth-best strikeout rate for pitchers with 300 innings.

David Ortiz – By this point everyone surely realizes that Ortiz has
snapped out of his early slump, but with his OPS still at a modest .733
not everyone is aware of just how good he’s been while slugging .617
with 11 homers, six doubles, and 29 RBIs in 35 games since the calendar
flipped to June. It should surprise no one if Ortiz posts a 1.000 OPS
in the second half.

Alexei Ramirez – Batting under .200 through 30 games has left
Ramirez’s overall stats looking sickly, but he’s at .318/.378/.484 with
10 homers in 55 games since. Ramirez has already drawn nearly twice as
many non-intentional walks as he did last year and is on pace for twice
as many steals. Despite the early hiccups, by season’s end he’ll likely
be a top-three fantasy shortstop.

Alex Rios – Rios is on pace for 20 homers, 40 doubles, 85 RBIs, and
25 steals, which is better all-around production than he managed last
season, but his .262 batting average is a career-low after he hit .302,
.297, and .291 in the previous three seasons. All of which adds up to
an ideal buy-low candidate, as Rios was a top-30 outfielder in the
first half and has room to move into the top 20.

Jimmy Rollins – Arguably the largest disappointment of the first
half, Rollins had a .227 batting average and .642 OPS after batting at
least .277 with a .770 OPS in each of the past five seasons. Throughout
the struggles he still showed plenty of power and speed with 29
extra-base hits and 16 steals, but an NL-worst .207 mark on balls in
play doomed him. That should be closer to .307 after the break.

Max Scherzer – Scherzer was one of my preseason breakout picks and
has lived up to expectations with a 3.64 ERA and 97 strikeouts in 96.1
innings, but his 5-6 record leaves him undervalued. He’s starting to
pitch deeper into games and has walked more than three batters just
once in his last 15 outings, so the wins figure to come easier for
Scherzer in the second half.

B.J. Upton – Upton missed the first week and got off to a brutal
start as he came back from offseason shoulder surgery, but has batted
.276/.352/.453 with seven homers, 24 total extra-base hits, and 24
steals in 55 games since mid-May. He’s a good bet to show even more
power in the second half, and only Willy Taveras and Jacoby Ellsbury
have swiped more bases since the beginning of last year.

Matt Wieters – Don’t let predictably failing to live up to the crazy
immediate hype convince you of anything other than the fact that
Wieters is human. Owners who expected him to arrive in the majors as a
fully formed MVP candidate have been disappointed, but he’s quietly hit
.300 with three homers and four doubles in the past two dozen games and
is capable of being a top-10 catcher going forward.

Jacob deGrom, oft-injured Rangers ace, to have season-ending right elbow surgery

rangers degrom
Charles LeClaire/USA TODAY Sports
2 Comments

ARLINGTON, Texas — The Texas Rangers signed Jacob deGrom to a $185 million, five-year deal in free agency last winter hoping the two-time NL Cy Young Award winner could help them get back to the playoffs for the first time since 2016 and make a push toward winning a World Series.

They also knew the risks, with the pitcher coming off two injury-plagued seasons with the New York Mets.

Even with deGrom sidelined since late April, the AL West-leading Rangers are off to the best start in franchise history – but now will be without their prized acquisition until at least next year. The team said Tuesday that deGrom will have season-ending surgery next week to repair a torn ulnar collateral ligament in his right elbow.

“We’ve got a special group here and to not be able to be out there and help them win, that stinks,” deGrom said, pausing several times with tears in his eyes. “Wanting to be out there and helping the team, it’s a disappointment.”

General manager Chris Young said Tuesday the decision on surgery came after an MRI on deGrom’s ailing right elbow, but the extent of what is required might not be determined until the operation is performed next week.

Tommy John surgery, in which the damaged ligament is replaced, is often needed to fix a torn UCL, but Young and the Rangers didn’t go as far as saying the pitcher would have that particular procedure. After being drafted by the New York Mets in 2010, deGrom made six starts in the minors that summer before needing Tommy John surgery and missing all of 2011, three years before his big league debut.

DeGrom last pitched April 28 against the New York Yankees, when he exited early because of injury concerns for the second time in a span of three starts. The announcement about surgery came a day after deGrom was transferred to the 60-day injured list.

Young said the latest MRI showed more inflammation and significant structural damage in the ligament that wasn’t there on the scan after deGrom left the game against the Yankees.

“The results of that MRI show that we have not made progress. And in fact, we’ve identified some damage to the ligament,” Young said. “It’s obviously a tough blow for Jacob, for certainly the Rangers. But we do feel this is what is right for Jacob in his career. We’re confident he’ll make a full recovery.”

Young and deGrom, who turns 35 later this month, said the goal is for the pitcher to return near the end of next season. Both said they were glad to have clarity on what was wrong with the elbow.

Texas won all six games started by deGrom (2-0), but the right-hander threw only 30 1/3 innings. He has a 2.67 ERA with 45 strikeouts and four walks. He threw 3 2/3 scoreless innings against the Yankees in his last start before leaving because of discomfort in his arm.

The Rangers went into Tuesday night’s game against St. Louis with a 39-20 record, the first time they were 19 games over .500 since the end of 2016, their last winning season.

Before going home to Florida over the weekend for the birth of his third child, deGrom threw his fifth bullpen last Wednesday in Detroit.

“I’d have days where I’d feel really good, days where I didn’t feel great. So I was kind of riding a roller coaster there for a little bit,” deGrom said. “They said originally there, we just saw some inflammation. … Getting an MRI right after you pitch, I feel like anybody would have inflammation. So, you know, I was hoping that that would get out of there and I would be fine. But it just didn’t work out that way.”

DeGrom spent his first nine big league seasons with the Mets, but was limited by injuries to 156 1/3 innings over 26 starts during his last two years in New York.

He had a career-low 1.08 ERA over 92 innings in 2021 before missing the final three months of the season with right forearm tightness and a sprained elbow.

The four-time All-Star didn’t make his first big league start last year until Aug. 2 after being shut down late in spring training because of a stress reaction in his right scapula.

His latest injury almost surely will trigger Texas’ conditional option on deGrom’s contract for 2028.

The option takes effect if deGrom has Tommy John surgery on his right elbow from 2023-26 or has any right elbow or shoulder injury that causes him to be on the IL for any period of 130 consecutive days during any season or 186 days in a row during any service period.

The conditional option would be for $20 million, $30 million or $37 million, depending on deGrom’s performance during the contract and health following the 2027 season.

“I feel bad for Jake. If I know Jake, he’ll have the surgery and come back and finish his career strong,” second-year Mets manager Buck Showalter said. “I know how much it means to him. He enjoys pitching. It’s certainly sad news for all of us.”